Henry Bio completed Series A financing

Jiangsu Hengrui Biomedical Technology Co., Ltd. was founded in 2019. The company is located in Taizhou City, Jiangsu Province. It mainly operates in the field of technology promotion and application services. Based on synthetic biology technology, biological fermentation technology and innovative materials, we have established a full industrial chain business system from raw materials to medical products, functional skin care products, and medical beauty. Recently, Jinbang Fund completed its Series A investment in Henry Bio. At present, the valuation of Henry Bio has reached 20 million US dollars. This investment will be used to complete the construction of the production line for recombinant human collagen series products and the promotion of medical product registration and application.

This article is reproduced from: https://www.itjuzi.com/investevent/13284946
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment

Your email address will not be published.